• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antidepressants in bipolar depression: an enduring controversy.双相抑郁中的抗抑郁药:一场持久的争论。
Int J Bipolar Disord. 2018 Dec 1;6(1):25. doi: 10.1186/s40345-018-0133-9.
2
Bipolar II disorder : epidemiology, diagnosis and management.双相II型障碍:流行病学、诊断与管理
CNS Drugs. 2007;21(9):727-40. doi: 10.2165/00023210-200721090-00003.
3
[Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part II: facts or artefacts?].[双相情感障碍中使用抗抑郁药存在禁忌的充分理由吗?第二部分:事实还是假象?]
Neuropsychiatr. 2007;21(2):131-58.
4
Pharmacotherapy of depression and mixed states in bipolar disorder.双相情感障碍中抑郁和混合状态的药物治疗
J Affect Disord. 2000 Sep;59 Suppl 1:S39-S56. doi: 10.1016/s0165-0327(00)00178-6.
5
Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder.抗抑郁药会影响情绪模式吗?一项关于双相情感障碍的自然主义研究。
Eur Psychiatry. 2006 Jun;21(4):262-9. doi: 10.1016/j.eurpsy.2006.04.009. Epub 2006 Jun 19.
6
ECNP consensus meeting. Bipolar depression. Nice, March 2007.欧洲神经精神药理学会共识会议。双相抑郁症。英国尼斯,2007年3月。
Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23.
7
Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines.2000年双相情感障碍的药物治疗:专家共识指南摘要
J Psychiatr Pract. 2000 Jul;6(4):197-211. doi: 10.1097/00131746-200007000-00004.
8
9
A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.抗抑郁药在双相抑郁治疗中作用的重新评估:来自斯坦利基金会双相情感障碍网络的数据
Bipolar Disord. 2003 Dec;5(6):396-406. doi: 10.1046/j.1399-5618.2003.00065.x.
10
The use of antidepressants in bipolar disorder.抗抑郁药在双相情感障碍中的应用。
J Clin Psychiatry. 2008 Aug;69(8):1307-18. doi: 10.4088/jcp.v69n0816.

引用本文的文献

1
Pharmaco-psychiatry and gut microbiome: a systematic review of effects of psychotropic drugs for bipolar disorder.药物精神病学与肠道微生物群:双相情感障碍精神药物疗效的系统评价
Microbiology (Reading). 2025 Jun;171(6). doi: 10.1099/mic.0.001568.
2
Risk of Switch to Mania/Hypomania in Bipolar Depressive Patients Treated with Antidepressants: A Real-World Study.双相抑郁患者使用抗抑郁药后转为躁狂/轻躁狂的风险:一项真实世界研究
Health Data Sci. 2025 Jun 3;5:0209. doi: 10.34133/hds.0209. eCollection 2025.
3
Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder.使用抗精神病药物治疗双相情感障碍的精准精神病学展望。
Brain Sci. 2025 Apr 23;15(5):430. doi: 10.3390/brainsci15050430.
4
Antidepressants in Bipolar Depression: From Neurotransmitter Mechanisms to Clinical Challenges.双相抑郁中的抗抑郁药:从神经递质机制到临床挑战
Actas Esp Psiquiatr. 2025 May;53(3):621-631. doi: 10.62641/aep.v53i3.1880.
5
Global Trends in the Use of Pharmacotherapy for the Treatment of Bipolar Disorder.双相情感障碍药物治疗的全球使用趋势
Curr Psychiatry Rep. 2025 May;27(5):239-247. doi: 10.1007/s11920-025-01606-8. Epub 2025 Mar 27.
6
Advancements in Valproate Therapy for Seizures, Migraines, and Bipolar Disorders.丙戊酸盐治疗癫痫、偏头痛和双相情感障碍的进展
Med Princ Pract. 2025;34(4):301-315. doi: 10.1159/000543555. Epub 2025 Jan 17.
7
Depression and anxiety management in cirrhosis.肝硬化患者抑郁和焦虑的管理
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000600. eCollection 2025 Jan 1.
8
Treatment of bipolar depression: clinical practice vs. adherence to guidelines-data from a Bavarian drug surveillance project.双相抑郁的治疗:临床实践与指南遵循情况——来自巴伐利亚药物监测项目的数据
Front Psychiatry. 2024 Jul 2;15:1425549. doi: 10.3389/fpsyt.2024.1425549. eCollection 2024.
9
Combining predominant polarity and affective spectrum concepts in bipolar disorder: towards a novel theoretical and clinical perspective.双相情感障碍中主要极性与情感谱概念的结合:迈向一种新颖的理论与临床视角。
Int J Bipolar Disord. 2024 May 2;12(1):14. doi: 10.1186/s40345-024-00336-9.
10
Global perspectives on bipolar disorder treatment: in-depth comparative analysis of international guidelines for medication selection.双相情感障碍治疗的全球视角:药物选择国际指南的深入比较分析
BJPsych Open. 2024 Apr 8;10(3):e75. doi: 10.1192/bjo.2024.27.

本文引用的文献

1
Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials.双相情感障碍长期抗抑郁治疗的疗效与安全性——随机对照试验的荟萃分析
J Affect Disord. 2017 Dec 1;223:41-48. doi: 10.1016/j.jad.2017.07.023. Epub 2017 Jul 11.
2
Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment.鲁拉西酮在双相情感障碍患者中的长期使用:两年治疗期的安全性和有效性
Int J Bipolar Disord. 2017 Dec;5(1):9. doi: 10.1186/s40345-017-0075-7. Epub 2017 Mar 2.
3
Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison.锂盐、舍曲林或两者联合治疗双相情感障碍 II 型抑郁急性期的转换率:一项随机双盲比较。
Am J Psychiatry. 2017 Mar 1;174(3):266-276. doi: 10.1176/appi.ajp.2016.15040558. Epub 2017 Jan 31.
4
Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.联用心境稳定剂或非典型抗精神病药物的第二代抗抑郁辅助治疗在急性双相抑郁中的安全性和有效性:一项随机安慰剂对照试验的系统评价和荟萃分析
Lancet Psychiatry. 2016 Dec;3(12):1138-1146. doi: 10.1016/S2215-0366(16)30264-4. Epub 2016 Oct 26.
5
Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: A meta-analysis.第二代抗精神病药物低剂量和高剂量治疗双相抑郁的利弊:一项荟萃分析。
J Psychiatr Res. 2017 May;88:38-46. doi: 10.1016/j.jpsychires.2016.12.021. Epub 2017 Jan 1.
6
Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.阿立哌唑辅助治疗抗抑郁药疗效欠佳的重度抑郁症成年患者的有效性和安全性:一项随机、双盲、安慰剂对照研究
J Clin Psychiatry. 2016 Mar;77(3):371-8. doi: 10.4088/JCP.15m10070.
7
The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial.拉瑞沙酮单药治疗对双相抑郁患者功能改善的直接和间接影响:一项随机安慰剂对照试验的结果。
Int J Bipolar Disord. 2016 Dec;4(1):7. doi: 10.1186/s40345-016-0049-1. Epub 2016 Mar 16.
8
Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.文拉法辛与锂盐单药治疗双相II型重度抑郁发作的短期疗效及心境转换率比较
Br J Psychiatry. 2016 Apr;208(4):359-65. doi: 10.1192/bjp.bp.115.169375. Epub 2016 Feb 18.
9
Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial.二代与一代抗抑郁药治疗双相II型抑郁:一项随机停药试验
J Clin Psychopharmacol. 2015 Oct;35(5):605-8. doi: 10.1097/JCP.0000000000000384.
10
Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.用于预防双相II型抑郁症复发的延续性抗抑郁药与心境稳定剂单药治疗的安全性和有效性:一项随机、双盲、平行组、前瞻性研究。
J Affect Disord. 2015 Oct 1;185:31-7. doi: 10.1016/j.jad.2015.05.070. Epub 2015 Jun 26.

双相抑郁中的抗抑郁药:一场持久的争论。

Antidepressants in bipolar depression: an enduring controversy.

作者信息

Gitlin Michael J

机构信息

Department of Psychiatry, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

出版信息

Int J Bipolar Disord. 2018 Dec 1;6(1):25. doi: 10.1186/s40345-018-0133-9.

DOI:10.1186/s40345-018-0133-9
PMID:30506151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6269438/
Abstract

The proper place and the optimal use of antidepressants in treating bipolar depression continues to be an area of great interest and greater controversy with passionate opinions more common than good studies. Even the handful of meta-analyses in the area disagree with each other. Overall, the evidence that antidepressants are effective in treating bipolar depression is weak. Additionally, many experts and clinicians worry greatly about the capacity of antidepressants to cause affective switching or mood destabilization. Yet, in short term controlled studies, with most patients also taking mood stabilizers, antidepressants are not associated with switches into mania/hypomania. Evidence of cycle acceleration with antidepressants primarily reflects treatment with older antidepressants, e.g., tricyclics. Similar evidence with modern antidepressants such as selective serotonin reuptake inhibitors (SSRIs) is lacking. The key questions should not be: are antidepressants effective in bipolar depression?; And: do antidepressants worsen the course of bipolar disorder? Rather, the question should be focused on subgroups: for which patients are antidepressants helpful and safe, and for which patients will they be harmful? Predictors of affective switching with antidepressants include: bipolar I disorder (vs. bipolar II), mixed features during depression, tricyclics vs. modern antidepressants, rapid cycling and possibly a history of drug abuse, especially stimulant abuse. Additionally, a number of recent studies have demonstrated both the safety and efficacy of antidepressant monotherapy in treating bipolar II depression. Finally, a subgroup of bipolar individuals need antidepressants in addition to mood stabilizers as part of an optimal maintenance treatment regimen.

摘要

抗抑郁药在双相抑郁治疗中的合理应用场所及最佳用法仍是一个备受关注且争议颇大的领域,充满激情的观点远比高质量研究更为常见。即便该领域为数不多的荟萃分析彼此之间也存在分歧。总体而言,抗抑郁药治疗双相抑郁有效的证据较为薄弱。此外,许多专家和临床医生极为担忧抗抑郁药引发情感转换或情绪不稳定的能力。然而,在短期对照研究中,大多数患者同时服用心境稳定剂,抗抑郁药与转换为躁狂/轻躁狂并无关联。抗抑郁药导致发作周期加速的证据主要反映的是使用如三环类等较老一代抗抑郁药的治疗情况。缺乏使用如选择性5-羟色胺再摄取抑制剂(SSRI)等现代抗抑郁药的类似证据。关键问题不应是:抗抑郁药对双相抑郁有效吗?以及:抗抑郁药会使双相情感障碍的病程恶化吗?相反,问题应聚焦于亚组:抗抑郁药对哪些患者有益且安全,对哪些患者有害?抗抑郁药引发情感转换的预测因素包括:双相I型障碍(相对于双相II型)、抑郁发作时的混合特征、三环类药物与现代抗抑郁药、快速循环发作以及可能存在的药物滥用史,尤其是兴奋剂滥用史。此外,近期的多项研究已证实抗抑郁药单药治疗双相II型抑郁的安全性和有效性。最后,作为最佳维持治疗方案的一部分,有一部分双相情感障碍患者除了需要心境稳定剂外,还需要抗抑郁药。